Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AGMB will rise by +9.76% over the next 2 Weeks and hit $17.45 by Tuesday, March 17, 2026. In that time frame, AGMB's share price is expected to range between $16.82 and $18.03.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 17, 2026 | 16.82 | 17.45 | 18.03 |
| Mar 16, 2026 | 16.78 | 17.34 | 17.86 |
| Mar 13, 2026 | 16.62 | 17.11 | 17.58 |
| Mar 12, 2026 | 16.81 | 17.20 | 17.61 |
| Mar 11, 2026 | 16.59 | 16.99 | 17.37 |
| Mar 10, 2026 | 16.44 | 16.78 | 17.10 |
| Mar 9, 2026 | 16.34 | 16.67 | 16.97 |
| Mar 6, 2026 | 16.17 | 16.44 | 16.71 |
| Mar 5, 2026 | 16.26 | 16.53 | 16.80 |
| Mar 4, 2026 | 16.06 | 16.32 | 16.61 |
AGMB shares fell -1.91% in Tuesday, March 3, 2026's trading session, dropping from a previous close of $16.21 to move at $15.90. The stock demonstrated notable intraday movement (see AGMB's key stats for a full breakdown), fluctuating between $15.08 and $17.45, a +15.73% trading range. While recent weeks have seen some volatility, AGMB has managed to secure a +8.16% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 83.5K shares changing hands, 23K more than the previous session. This amounted to $1.33M in total market activity.
Will AGMB Continue Its Upward Trend?
According to analyst ratings and projections for AGMB, AgomAb Therapeutics N.V. American Depositary Shares shares are anticipated to increase by +11.84%, potentially reaching $18.03 per share by March 17, 2026. Short-term technical indicators currently suggest a neutral sentiment for AGMB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 6 positive trading days within the past 30 sessions. Based on the AGMB stock forecast, now is a good time to buy AGMB stock because its current trading price is -8.89% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AGMB covering social and institutional perspectives.
AGMB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AGMB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 0.00% to 61.32%) suggest weak bearish momentum with possible fluctuation.Insights into AGMB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
AgomAb Therapeutics NV American Depositary Shares Short-Term Forecasts
AGMB Forecast For Next 5 Days
Our algorithm anticipates AgomAb Therapeutics NV American Depositary Shares (AGMB) stock could hit $18.76 by Mar 10, 2026. This represents a +17.97% fall from today's price, following a - change over the past five days.
AGMB Forecast For Next 30 Days
Based on analysis of market trends, the outlook for AgomAb Therapeutics N.V. American Depositary Shares (AGMB) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $15.28, which would mean a -3.90% decrease from the current price of $15.90. Projections for this period range from a high of $21.24 to a low of $1.31.
AGMB Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for AgomAb Therapeutics NV American Depositary Shares's price over the next three months point to a rise. AGMB stock is expected to peak at $277.81 on Mar 16, 2026 before potentially dipping to $0.00 on Jun 01, 2026. On average, AGMB is likely to trade around $63.46 in the coming 90 days.
AgomAb Therapeutics NV American Depositary Shares Stock Forecast 2025
Based on our predictive models, AgomAb Therapeutics NV American Depositary Shares (AGMB) is expected to trade between $0.00 and $368.21 throughout 2026. This would result in an average price of $96.39, potentially offering investors a +506.23% return from current levels.
AgomAb Therapeutics N.V. American Depositary Shares Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in March 2026. The price is predicted to move between $0.00 and $277.81, settling at an average of $97.45. This could translate to a +512.89% gain.
April 2026
Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend april 2026. We forecast a trading range from $0.00 to $141.74, with a likely average price of $41.42. Investors could expect a potential return of +160.50%.
May 2026
Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in May 2026. The expected range spans $0.00–$137.88, with an average target of $52.07. This represents a positive outlook and a possible gain of +227.48%.
June 2026
Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in June 2026. Projections place the stock between $0.00 and $331.18, averaging around $121.88. This suggests a +666.54% gain from current levels.
July 2026
Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during July 2026. Prices could fluctuate within $65.52 to $153.48, with a midpoint forecast of $75.07. The stock might deliver a +372.14% gain.
August 2026
Forecasting for August 2026, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $327.51, averaging $129.59. This signals a positive trajectory with potential returns around +715.03%.
September 2026
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $198.05, settling at an average of $77.81. This could translate to a +389.37% gain.
October 2026
Based on current market signals, AgomAb Therapeutics N.V. American Depositary Shares is projected to trend october 2026. We forecast a trading range from $0.00 to $175.03, with a likely average price of $69.41. Investors could expect a potential return of +336.54%.
November 2026
Our predictive algorithms indicate AgomAb Therapeutics N.V. American Depositary Shares stock may see a shift in November 2026. The expected range spans $0.00–$368.21, with an average target of $183.82. This represents a positive outlook and a possible gain of +1,056.10%.
December 2026
Analyzing established trends, AgomAb Therapeutics N.V. American Depositary Shares looks set to move in December 2026. Projections place the stock between $115.23 and $136.92, averaging around $118.91. This suggests a +647.86% gain from current levels.
January 2027
Market indicators suggest AgomAb Therapeutics N.V. American Depositary Shares could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $367.66, with a midpoint forecast of $188.09. The stock might deliver a +1,082.96% gain.
February 2027
Forecasting for February 2027, models estimate that AgomAb Therapeutics N.V. American Depositary Shares may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $211.03, averaging $91.75. This signals a positive trajectory with potential returns around +477.04%.
March 2027
According to our latest forecast models, AgomAb Therapeutics N.V. American Depositary Shares (AGMB) is positioned to show a strong performance in March 2027. The price is predicted to move between $196.82 and $224.73, settling at an average of $213.69. This could translate to a +1,243.96% gain.
AGMB's history of dividends and stock splits also plays a role in long-term investor confidence.

